Lanean...
Limitations to antiarrhythmic drug use in patients with atrial fibrillation
BACKGROUND: Of the antiarrhythmic agents currently marketed in Canada, 5 are commonly used to treat atrial fibrillation (AF). The impact of contraindications, warnings and precautions for the use of these drugs in patients with AF is not known. We evaluated the proportion of patients with AF for who...
Gorde:
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Canadian Medical Association
2004
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC517859/ https://ncbi.nlm.nih.gov/pubmed/15451836 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1503/cmaj.1031277 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|